全球活細胞成像市場：展望與預測（2022-2027）

從 2022 年到 2027 年，全球活細胞成像市場規模預計將以 8.44% 的複合年增長率增長。

活細胞成像技術使科學家能夠實時研究細胞結構和過程。這些因素對市場增長有重大影響。全球活細胞成像市場受到以下因素的推動：死亡人數和慢性病人數增加，以及由於再生醫學需求增加導致細胞和基因治療投資急劇增加，主要是在發達國家。因素。

本報告審視了全球活細胞成像市場，展示了市場機會和趨勢、市場增長關鍵、市場格局、市場規模和按細分市場預測、按地區/主要國家/地區細分、競爭格局、主要收集公司概況。

內容

第一章研究方法

第二章研究目的

第三章研究過程

第四章範圍

第 5 章報告假設和註釋

第 6 章市場概述

第七章介紹

• 概覽

第 8 章重要注意事項

• 活細胞成像的世界市場情景
  • 市場細分
  • 競爭格局
  • 全球活細胞成像市場的最新發展

第 9 章市場機會和趨勢

• 利用深度學習和人工智能改進活細胞成像技術
• 增加對細胞和基因治療產品的投資
• 活細胞成像跟蹤解決方案
• 活細胞成像技術的進步

第 10 章市場增長的關鍵

• 癌症和傳染病患者人數增加
• 高內涵篩選 (HCS) 方法介紹
• 活細胞成像新技術
• 擴大製藥行業的研發活動

第 11 章市場限制

• 活細胞成像系統的高成本
• 細胞活力和細胞環境維護面臨的挑戰
• 熒光顯微鏡下的光毒性和光漂白

第 12 章市場條件

• 市場概覽
• 市場規模和預測
  • 討論：按產品分類
  • 討論：按方法
  • 注意事項：按應用程序
  • 討論：最終用戶
  • 討論：按地區
• 五力分析
  • 新進入者的威脅
  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 競爭對手之間的競爭情況

第 13 章產品

• 市場快照/增長引擎
• 市場概覽
• 設備
  • 市場概覽
  • 市場規模和預測
  • 設備：區域細分
• 消耗品
  • 市場概覽
  • 市場規模和預測
  • 消耗品：區域細分
• 軟件
  • 市場概覽
  • 市場規模和預測
  • 軟件：區域細分

第 14 章技術

• 市場快照/增長引擎
• 市場概覽
• 熒光顯微鏡
  • 市場概覽
  • 市場規模和預測
  • 熒光顯微鏡：區域分割
• 共聚焦顯微鏡
  • 市場概覽
  • 市場規模和預測
  • 共聚焦顯微鏡：區域分割
• 透射光顯微鏡
  • 市場概覽
  • 市場規模和預測
  • 透射光顯微鏡：區域分割
• 其他
  • 市場概覽
  • 市場規模和預測
  • 其他：區域細分

第 15 章用途

• 市場快照/增長引擎
• 市場概覽
• 細胞生物學
  • 市場概覽
  • 市場規模和預測
  • 細胞生物學：區域分割
• 藥物發現
  • 市場概覽
  • 市場規模和預測
  • 藥物發現：區域細分
• 發育生物學
  • 市場概覽
  • 市場規模和預測
  • 發育生物學：區域分割
• 幹細胞研究
  • 市場概覽
  • 市場規模和預測
  • 幹細胞研究：區域細分

第 16 章。最終用戶

• 市場快照/增長引擎
• 市場概覽
• 製藥和生物技術公司
  • 市場概覽
  • 市場規模和預測
  • 製藥和生物技術公司：區域細分
• 學術和研究機構
  • 市場概覽
  • 市場規模和預測
  • 學術和研究機構：按地區劃分
• 其他
  • 市場概覽
  • 市場規模和預測
  • 其他：區域細分

第 17 章區域

• 市場快照/增長引擎
• 地理概覽

第 18 章北美

• 市場概覽
• 市場規模和預測
  • 北美：產品
  • 北美：方法論
  • 北美：應用
  • 北美：最終用戶
• 主要國家
  • 美國：市場規模和預測
  • 加拿大：市場規模和預測

第 19 章歐洲

• 市場概覽
• 市場規模和預測
  • 歐洲：產品
  • 歐洲：方法論
  • 歐洲：應用
  • 歐洲：最終用戶
• 主要國家
  • 德國：市場規模和預測
  • 法國：市場規模和預測
  • 英國：市場規模和預測
  • 意大利：市場規模和預測
  • 西班牙：市場規模和預測

第 20 章亞太地區

• 市場概覽
• 市場規模和預測
  • 亞太地區：產品
  • 亞太地區：方法論
  • 亞太地區：應用
  • 亞太地區：最終用戶
• 主要國家
  • 中國：市場規模和預測
  • 日本：市場規模和預測
  • 印度：市場規模和預測
  • 韓國：市場規模和預測
  • 澳大利亞：市場規模和預測

第 21 章拉丁美洲

• 市場概覽
• 市場規模和預測
  • 拉丁美洲：產品
  • 拉丁美洲：方法論
  • 拉丁美洲：應用
  • 拉丁美洲：最終用戶
• 主要國家
  • 巴西：市場規模和預測
  • 墨西哥：市場規模和預測
  • 阿根廷：市場規模和預測

第 22 章中東和非洲

• 市場概覽
• 市場規模和預測
  • 中東和非洲：產品
  • 中東和非洲：方法論
  • 中東和非洲：應用
  • 中東和非洲：最終用戶
• 主要國家
  • 土耳其：市場規模和預測
  • 沙特阿拉伯：市場規模和預測
  • 南非：市場規模和預測
  • 阿拉伯聯合酋長國：市場規模和預測

第 23 章競爭格局

• 比賽總結
• 市場份額分析
  • DANAHER
  • AGILENT TECHNOLOGIES
  • PERKINELMER
  • MERCK KGAA
  • ZEISS
  • THERMO FISHER SCIENTIFIC

第 24 章主要公司簡介

• DANAHER
• AGILENT TECHNOLOGIES
• PERKINELMER
• MERCK KGAA
• ZEISS
• THERMO FISHER SCIENTIFIC

第25章其他知名公司

• AXION BIOSYSTEMS
• BD
• BIO-RAD LABORATORIES
• BLUE-RAY BIOTECH
• BRUKER
• EPPENDORF
• ETALUMA
• GRACE BIO-LABS
• IBIDI GMBH
• INTELLIGENT IMAGING INNOVATIONS
• KEYENCE CORPORATION
• LOGOS BIOSYSTEMS
• NANOENTEK
• NANOLIVE SA
• NIKON
• EVIDENT
• ONI
• OXFORD INSTRUMENTS
• PHASE FOCUS
• PHASE HOLOGRAPHIC IMAGING PHI AB
• PROTEINTECH GROUP
• SARTORIUS AG
• SONY BIOTECHNOLOGY
• TOMOCUBE

第 26 章。報告概述

• 重點
• 戰略建議

第27章定量總結

• 按產品分類
  • 北美：產品細分
  • 歐洲：產品細分
  • 亞太地區：產品細分
  • 拉丁美洲：產品細分
  • 中東和非洲：產品細分
• 按方法營銷
  • 北美：技術細分
  • 歐洲：方法細分
  • 亞太地區：方法細分
  • 拉丁美洲：方法細分
  • 中東和非洲：方法細分
• 按應用進行營銷
  • 北美：應用細分
  • 歐洲：應用細分
  • 亞太地區：應用細分
  • 拉丁美洲：應用細分
  • 中東和非洲：應用細分
• 按最終用戶劃分的市場
  • 北美：最終用戶細分
  • 歐洲：最終用戶細分
  • 亞太地區：最終用戶細分
  • 拉丁美洲：最終用戶細分
  • 中東和非洲：最終用戶細分
• 區域市場
  • 設備：區域分割
  • 消耗品：區域細分
  • 軟件：區域分割
  • 熒光顯微鏡：區域分割
  • 共聚焦顯微鏡：區域分割
  • 透射光顯微鏡：區域分割
  • 其他：區域細分
  • 細胞生物學：區域分割
  • 藥物發現：區域細分
  • 發育生物學：區域分割
  • 幹細胞研究：區域細分
  • 製藥和生物技術公司：區域細分
  • 學術和研究機構：區域細分
  • 其他：區域細分

第 28 章附錄

The global live cell imaging market is expected to grow at a CAGR of 8.44% during 2022-2027.

MARKET INSIGHTS

Live cell imaging is one of the popular techniques for studying live cells and investigating the biological processes in real-time. It utilizes time-lapse microscopy and careful preparation of living cell environments that have made it easier to observe cell-to-cell interactions and study the behavior of single cells and related changes within the cell. In 2021, North America accounted for the highest share of the global live cell imaging market.

Live cell imaging has revolutionized studying cells, processes, and molecular interactions. Imaging techniques for living cells allow scientists to study cell structures and processes in real-time and over time. Such factors have significantly impacted the growth of the market. A few of the most widespread applications include examining the structural components of a cell, the dynamic studying processes, and the localization of molecules.

MARKET TRENDS & DRIVERS

Rising Target Patient Population

Live cell imaging is a vital tool in the study of cancer biology. Although high-resolution imaging is indispensable for studying genetic and cell signaling changes in underlying cancer, live cell imaging is essential for a deeper understanding of the function and disease mechanisms. Around 400,000 children develop cancer every year. Developed and emerging countries are facing the burden of communicable diseases. Most developing countries get exposed due to several factors that include demographic, socio-economic, and geographic conditions. Hence, the growing number of deaths and chronic conditions drive the live cell imaging market.

Deep Learning & Artificial Intelligence

The role of Artificial intelligence (AI) in life science is rapidly expanding and holds great potential for microscopy. In the past, the power of microscopy for supporting or disproving scientific hypotheses got limited by scale, and the time associated with quantifying, capturing, and analyzing large numbers of images was often prohibitive. Recently, AI has made fast inroads into many scientific fields and the world of microscopy. AI-based self-learning microscopy shows the potential to produce high throughput image analysis that is more effortless and less time-consuming. Newer AI technology allows better visualization of unlabeled live cells over a prolonged period.

Increase in Funding for Cell & Gene Therapy

The demand for regenerative medicine has increased across developed countries, and investments in cell & gene therapy have grown drastically in recent years. The public and private sectors are at the forefront of funding cell and gene therapy developers. Recently, many government organizations and private firms have started funding many biotech start-ups and research institutes that invest in the R&D of cell and gene therapy products. According to the Alliance for Regenerative Medicines, there was a 164% jump in funding for cell & gene therapy in 2019 compared to 2017.

Advancements & Newer Imaging Techniques

Live cell imaging arises from scientific interest coupled with imaging and labeling technology improvements. Putting together various technological advancements with biological interests gives scientists many more ways to use live cell imaging. In particular, exciting progress in probe development has enabled a broad array of nucleic acids, proteins, glycans, lipids, ions, metabolites, and other targets to be labeled. Many recent advancements in microscopic technologies use software that enables a better quantitative image analysis of label-free images.

Also, current microscopy techniques limit the quantity and quality of information available to researchers and clinicians and harm the living cells during long-term studies. Hence new imaging technologies are being developed to overcome various limitations. These advancements will help towards future market growth. For instance, the progress of combining 3D fluorescence imaging and holotomography microscopy has overcome some limitations.

Growing Research-based Activities

In the past two decades, the spending on R&D and the introduction of newer drugs have increased rapidly. In 2019, the pharma industry spent around $83 billion on R&D. From 2010 to 2019, the number of novel drugs were approved, whose sales increased by 60% compared with the previous decade, with a peak of 59 new drugs approved in 2018. The rising amount of R&D expenditure and the number of R&D activities in the pharmaceutical sector has led to the significant growth of the market.

SEGMENTATION ANALYSIS

• The global live cell imaging market by product includes sub-segments by equipment, consumables, and software. In 2021, the equipment sector accounted for the highest share in the global live cell imaging market.

Under the equipment sector, live-cell imaging microscopes are opening novel and exciting avenues for studying cellular health, viability, colony formation, migration, and cellular responses to external stimuli. The demand for microscopes is at a larger scale, majorly due to the technological advancements in microscopes and increasing studies into cell behavior.

• Fluorescence microscopy, confocal microscopy, transmitted light microscopy, and other techniques are included in the global live cell imaging market by technique. Fluorescence microscopy held the largest share of 53.68% in the global live cell imaging market in 2021. Live-cell imaging techniques are involved in a wide spectrum of imaging modalities, including widefield fluorescence, confocal, multiphoton, total internal reflection, FRET, lifetime imaging, super-resolution, and transmitted light microscopy.
• An increasing number of investigations are using live-cell imaging techniques. Owing to these advances, live-cell imaging has become a requisite analytical tool in most cell biology laboratories. Cell biology, drug discovery, developmental biology, and stem cell are the application's primary segments of the live cell imaging market. In 2021, cell biology accounted for the highest share of 38.72% in the global live cell imaging market.
• The end-user market includes segments by pharma & biotech companies, academic & research institutes, and others. Academic and research institutions identify promising discoveries and seek to initiate their development and commercialization. Most new insights into biology, disease, and new technologies arise in academia, funded by public grants, foundations, and institutional funds. The discovery and development of new therapies have and will likely continue to require contributions from academic institutions and the biopharmaceutical industry.

Segmentation by Product Type

• Equipment
• Consumables
• Software

Segmentation by Technique

• Fluorescence microscopy
• Confocal microscopy
• Transmitted light microscopy
• Others

Segmentation by Application

• Cell Biology
• Drug Discovery
• Developmental Biology
• Stem Cells

Segmentation by End-Users

• Pharma & Biotech Companies
• Academic & research centers
• Others

GEOGRAPHIC ANALYSIS

By geography, the report includes North America, Europe, APAC, Latin America, and the Middle East & Africa. In 2021, North America accounted for the highest share of the global live cell imaging market.

Live cell imaging systems are used for diagnostics purposes, drug discovery & development, and precision medicine. The increase in healthcare expenditures and funding for R&D activities for live cells-driven drug discovery, development, and personalized medicine is one of the major driving factors for leading the North American region. Europe holds the second-largest share of the global market, owing to a growing patient population in need of new treatments such as stem cell therapy and gene therapy, an increasing number of drug approvals for precision medicine, government funding for research-based activities, rapid advancements in live cell imaging, and a variety of other factors.

The APAC region will likely witness the fastest growth in the global live cell imaging market. The significant factors behind this growth can be due to the constant rise in cancers and infectious diseases, growing demand for stem cell research studies, rising R&D expenditures, the increased utility of biomarkers for diagnostic purposes, rising awareness for cell & gene therapies, need for precision medicine, and advances in drug discovery & cell and biology development. However, Latin America and Middle East & Africa accounted for minimal shares in the global market.

Segmentation by Geography

• North America
  • THE US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
• APAC
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • South Africa
  • UAE

COMPETITIVE LANDSCAPE

The leading players in the market are implementing various strategies such as marketing and promotional activities, mergers & acquisitions, product launches, and approvals. Also, high R&D investments and boosting distribution networks have helped companies enhance their market share and presence.

The global live cell imaging market includes global and regional players. Major players contributing to the market's significant shares include Agilent, Bruker, Carl Zeiss AG, Danaher, Merck KGaA, PerkinElmer, and Thermo Fisher Scientific. Other prominent players in the market include Axion (CytoSMART Technologies), Bio-Rad Laboratories, blue-ray biotech, Etaluma, Grace Bio Labs, ibidi GmbH, KEYENCE, NanoEnTek, Nanolive SA, Nikon, Olympus, and others.

Recent Developments in the Global Market

• In 2021, CytoSMART launched CytoSMART Lux3 BR, a new type of bright-field microscope, i.e., a live-cell imaging microscope equipped with a high-quality CMOS camera to assist label-free cell imaging procedures.
• In 2021, the Zeiss group announced that they would launch Zeiss Visioner 1, a Zeiss live cell imaging system, an innovative digital microscope that facilitates real-time all-in-one focus via a micro-mirror array system.
• In 2020, CytoSMART Technologies launched CytoSMART Multi Lux, a remote live cell imaging system.

Key Vendors

• Danaher
• Agilent Technologies
• PerkinElmer
• Merck KGaA
• ZEISS
• Thermo Fisher Scientific

Other Prominent Vendors

• Axion BioSystems
• BD
• Bio-Rad Laboratories
• Blue-Ray Biotech
• Bruker
• Eppendorf
• Etaluma
• Grace Bio-Labs
• ibidi GmbH
• Intelligent Imaging Innovations
• KEYENCE
• Logos Biosystems
• NanoEntek
• Nanolive SA
• Nikon
• Evident
• ONI
• Oxford Instruments
• Phase Focus
• Phase Holographic Imaging PHI AB
• Proteintech Group
• Sartorius AG
• Sony Biotechnology
• Tomocube

KEY QUESTIONS ANSWERED

• 1. What is the expected live cell imaging market size by 2027?
• 2. What is the live cell imaging market growth?
• 3. What are the latest trends in the live cell imaging market?
• 4. Who are the market leaders in the global live cell imaging market?
• 5. Which region has the largest live cell imaging market share?

TABLE OF CONTENTS

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

• 4.1 MARKET DEFINITION
  • 4.1.1 INCLUSIONS
  • 4.1.2 EXCLUSIONS
  • 4.1.3 MARKET ESTIMATION CAVEATS
• 4.2 BASE YEAR
• 4.3 SCOPE OF THE STUDY
  • 4.3.1 MARKET SEGMENTATION BY PRODUCT
  • 4.3.2 MARKET SEGMENTATION BY TECHNIQUE
  • 4.3.3 MARKET SEGMENTATION BY APPLICATION
  • 4.3.4 MARKET SEGMENTATION BY END-USER
  • 4.3.5 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

• 5.1 KEY CAVEATS
• 5.2 CURRENCY CONVERSION
• 5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 INTRODUCTION

• 7.1 OVERVIEW

8 PREMIUM INSIGHTS

• 8.1 GLOBAL LIVE-CELL IMAGING MARKET SCENARIO
  • 8.1.1 MARKET SEGMENTATIONS
  • 8.1.2 COMPETITIVE LANDSCAPE
  • 8.1.3 RECENT DEVELOPMENTS IN GLOBAL LIVE-CELL IMAGING MARKET

9 MARKET OPPORTUNITIES & TRENDS

• 9.1 DEEP LEARNING & ARTIFICIAL INTELLIGENCE ENHANCE LIVE-CELL IMAGING TECHNIQUES
• 9.2 INCREASED INVESTMENTS IN CELL & GENE THERAPY PRODUCTS
• 9.3 TRACKING SOLUTIONS FOR LIVE-CELL IMAGING
• 9.4 ADVANCES IN LIVE-CELL IMAGING

10 MARKET GROWTH ENABLERS

• 10.1 RISE IN NUMBER OF PATIENTS WITH CANCERS & INFECTIOUS DISEASES
• 10.2 ADOPTION OF HCS METHODS
• 10.3 NEW TECHNIQUES IN LIVE-CELL IMAGING
• 10.4 GROWTH IN R&D ACTIVITIES IN PHARMACEUTICAL INDUSTRY

11 MARKET RESTRAINTS

• 11.1 HIGH COST OF LIVE-CELL IMAGING SYSTEMS
• 11.2 CELL VIABILITY & CELLULAR ENVIRONMENT MAINTENANCE CHALLENGES
• 11.3 PHOTOTOXICITY & PHOTOBLEACHING IN FLUORESCENCE MICROSCOPY

12 MARKET LANDSCAPE

• 12.1 MARKET OVERVIEW
• 12.2 MARKET SIZE & FORECAST
  • 12.2.1 INSIGHTS BY PRODUCT
  • 12.2.2 INSIGHTS BY TECHNIQUE
  • 12.2.3 INSIGHTS BY APPLICATION
  • 12.2.4 INSIGHTS BY END-USER
  • 12.2.5 INSIGHTS BY GEOGRAPHY
• 12.3 FIVE FORCES ANALYSIS
  • 12.3.1 THREAT OF NEW ENTRANTS
  • 12.3.2 BARGAINING POWER OF SUPPLIERS
  • 12.3.3 BARGAINING POWER OF BUYERS
  • 12.3.4 THREAT OF SUBSTITUTES
  • 12.3.5 COMPETITIVE RIVALRY

13 PRODUCT

• 13.1 MARKET SNAPSHOT & GROWTH ENGINE
• 13.2 MARKET OVERVIEW
• 13.3 EQUIPMENT
  • 13.3.1 MARKET OVERVIEW
  • 13.3.2 MARKET SIZE & FORECAST
  • 13.3.3 EQUIPMENT: GEOGRAPHY SEGMENTATION
• 13.4 CONSUMABLES
  • 13.4.1 MARKET OVERVIEW
  • 13.4.2 MARKET SIZE & FORECAST
  • 13.4.3 CONSUMABLES: GEOGRAPHY SEGMENTATION
• 13.5 SOFTWARE
  • 13.5.1 MARKET OVERVIEW
  • 13.5.2 MARKET SIZE & FORECAST
  • 13.5.3 SOFTWARE: GEOGRAPHY SEGMENTATION

14 TECHNIQUE

• 14.1 MARKET SNAPSHOT & GROWTH ENGINE
• 14.2 MARKET OVERVIEW
• 14.3 FLUORESCENCE MICROSCOPY
  • 14.3.1 MARKET OVERVIEW
  • 14.3.2 MARKET SIZE & FORECAST
  • 14.3.3 FLUORESCENCE MICROSCOPY: GEOGRAPHY SEGMENTATION
• 14.4 CONFOCAL MICROSCOPY
  • 14.4.1 MARKET OVERVIEW
  • 14.4.2 MARKET SIZE & FORECAST
  • 14.4.3 CONFOCAL MICROSCOPY: GEOGRAPHY SEGMENTATION
• 14.5 TRANSMITTED LIGHT MICROSCOPY
  • 14.5.1 MARKET OVERVIEW
  • 14.5.2 MARKET SIZE & FORECAST
  • 14.5.3 TRANSMITTED LIGHT MICROSCOPY: GEOGRAPHY SEGMENTATION
• 14.6 OTHERS
  • 14.6.1 MARKET OVERVIEW
  • 14.6.2 MARKET SIZE & FORECAST
  • 14.6.3 OTHERS: GEOGRAPHY SEGMENTATION

15 APPLICATION

• 15.1 MARKET SNAPSHOT & GROWTH ENGINE
• 15.2 MARKET OVERVIEW
• 15.3 CELL BIOLOGY
  • 15.3.1 MARKET OVERVIEW
  • 15.3.2 MARKET SIZE & FORECAST
  • 15.3.3 CELL BIOLOGY: GEOGRAPHY SEGMENTATION
• 15.4 DRUG DISCOVERY
  • 15.4.1 MARKET OVERVIEW
  • 15.4.2 MARKET SIZE & FORECAST
  • 15.4.3 DRUG DISCOVERY: GEOGRAPHY SEGMENTATION
• 15.5 DEVELOPMENTAL BIOLOGY
  • 15.5.1 MARKET OVERVIEW
  • 15.5.2 MARKET SIZE & FORECAST
  • 15.5.3 DEVELOPMENTAL BIOLOGY: GEOGRAPHY SEGMENTATION
• 15.6 STEM CELL RESEARCH
  • 15.6.1 MARKET OVERVIEW
  • 15.6.2 MARKET SIZE & FORECAST
  • 15.6.3 STEM CELL RESEARCH: GEOGRAPHY SEGMENTATION

16 END-USER

• 16.1 MARKET SNAPSHOT & GROWTH ENGINE
• 16.2 MARKET OVERVIEW
• 16.3 PHARMA & BIOTECH COMPANIES
  • 16.3.1 MARKET OVERVIEW
  • 16.3.2 MARKET SIZE & FORECAST
  • 16.3.3 PHARMA & BIOTECH COMPANIES: GEOGRAPHY SEGMENTATION
• 16.4 ACADEMIC & RESEARCH INSTITUTES
  • 16.4.1 MARKET OVERVIEW
  • 16.4.2 MARKET SIZE & FORECAST
  • 16.4.3 ACADEMIC & RESEARCH INSTITUTES: GEOGRAPHY SEGMENTATION
• 16.5 OTHERS
  • 16.5.1 MARKET OVERVIEW
  • 16.5.2 MARKET SIZE & FORECAST
  • 16.5.3 OTHERS: GEOGRAPHY SEGMENTATION

17 GEOGRAPHY

• 17.1 MARKET SNAPSHOT & GROWTH ENGINE
• 17.2 GEOGRAPHIC OVERVIEW

18 NORTH AMERICA

• 18.1 MARKET OVERVIEW
• 18.2 MARKET SIZE & FORECAST
  • 18.2.1 NORTH AMERICA: PRODUCT
  • 18.2.2 NORTH AMERICA: TECHNIQUE
  • 18.2.3 NORTH AMERICA: APPLICATION
  • 18.2.4 NORTH AMERICA: END-USER
• 18.3 KEY COUNTRIES
  • 18.3.1 US: MARKET SIZE & FORECAST
  • 18.3.2 CANADA: MARKET SIZE & FORECAST

19 EUROPE

• 19.1 MARKET OVERVIEW
• 19.2 MARKET SIZE & FORECAST
  • 19.2.1 EUROPE: PRODUCT
  • 19.2.2 EUROPE: TECHNIQUE
  • 19.2.3 EUROPE: APPLICATION
  • 19.2.4 EUROPE: END-USER
• 19.3 KEY COUNTRIES
  • 19.3.1 GERMANY: MARKET SIZE & FORECAST
  • 19.3.2 FRANCE: MARKET SIZE & FORECAST
  • 19.3.3 UK: MARKET SIZE & FORECAST
  • 19.3.4 ITALY: MARKET SIZE & FORECAST
  • 19.3.5 SPAIN: MARKET SIZE & FORECAST

20 APAC

• 20.1 MARKET OVERVIEW
• 20.2 MARKET SIZE & FORECAST
  • 20.2.1 APAC: PRODUCT
  • 20.2.2 APAC: TECHNIQUE
  • 20.2.3 APAC: APPLICATION
  • 20.2.4 APAC: END-USER
• 20.3 KEY COUNTRIES
  • 20.3.1 CHINA: MARKET SIZE & FORECAST
  • 20.3.2 JAPAN: MARKET SIZE & FORECAST
  • 20.3.3 INDIA: MARKET SIZE & FORECAST
  • 20.3.4 SOUTH KOREA: MARKET SIZE & FORECAST
  • 20.3.5 AUSTRALIA: MARKET SIZE & FORECAST

21 LATIN AMERICA

• 21.1 MARKET OVERVIEW
• 21.2 MARKET SIZE & FORECAST
  • 21.2.1 LATIN AMERICA: PRODUCT
  • 21.2.2 LATIN AMERICA: TECHNIQUE
  • 21.2.3 LATIN AMERICA: APPLICATION
  • 21.2.4 LATIN AMERICA: END-USER
• 21.3 KEY COUNTRIES
  • 21.3.1 BRAZIL: MARKET SIZE & FORECAST
  • 21.3.2 MEXICO: MARKET SIZE & FORECAST
  • 21.3.3 ARGENTINA: MARKET SIZE & FORECAST

22 MIDDLE EAST & AFRICA

• 22.1 MARKET OVERVIEW
• 22.2 MARKET SIZE & FORECAST
  • 22.2.1 MIDDLE EAST & AFRICA: PRODUCT
  • 22.2.2 MIDDLE EAST & AFRICA: TECHNIQUE
  • 22.2.3 MIDDLE EAST & AFRICA: APPLICATION
  • 22.2.4 MIDDLE EAST & AFRICA: END-USER
• 22.3 KEY COUNTRIES
  • 22.3.1 TURKEY: MARKET SIZE & FORECAST
  • 22.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST
  • 22.3.3 SOUTH AFRICA: MARKET SIZE & FORECAST
  • 22.3.4 UAE: MARKET SIZE & FORECAST

23 COMPETITIVE LANDSCAPE

• 23.1 COMPETITION OVERVIEW
• 23.2 MARKET SHARE ANALYSIS
  • 23.2.1 DANAHER
  • 23.2.2 AGILENT TECHNOLOGIES
  • 23.2.3 PERKINELMER
  • 23.2.4 MERCK KGAA
  • 23.2.5 ZEISS
  • 23.2.6 THERMO FISHER SCIENTIFIC

24 KEY COMPANY PROFILES

• 24.1 DANAHER
  • 24.1.1 BUSINESS OVERVIEW
  • 24.1.2 DANAHER IN GLOBAL LIVE-CELL IMAGING MARKET
  • 24.1.3 PRODUCT OFFERINGS
  • 24.1.4 KEY STRATEGIES
  • 24.1.5 KEY STRENGTHS
  • 24.1.6 KEY OPPORTUNITIES
• 24.2 AGILENT TECHNOLOGIES
  • 24.2.1 BUSINESS OVERVIEW
  • 24.2.2 AGILENT TECHNOLOGIES IN GLOBAL LIVE-CELL IMAGING MARKET
  • 24.2.3 PRODUCT OFFERINGS
  • 24.2.4 KEY STRATEGIES
  • 24.2.5 KEY STRENGTHS
  • 24.2.6 KEY OPPORTUNITIES
• 24.3 PERKINELMER
  • 24.3.1 BUSINESS OVERVIEW
  • 24.3.2 PERKINELMER IN GLOBAL LIVE-CELL IMAGING MARKET
  • 24.3.3 PRODUCT OFFERINGS
  • 24.3.4 KEY STRATEGIES
  • 24.3.5 KEY STRENGTHS
  • 24.3.6 KEY OPPORTUNITIES
• 24.4 MERCK KGAA
  • 24.4.1 BUSINESS OVERVIEW
  • 24.4.2 MERCK KGAA IN GLOBAL LIVE-CELL IMAGING MARKET
  • 24.4.3 PRODUCT OFFERINGS
  • 24.4.4 KEY STRATEGIES
  • 24.4.5 KEY STRENGTHS
  • 24.4.6 KEY OPPORTUNITIES
• 24.5 ZEISS
  • 24.5.1 BUSINESS OVERVIEW
  • 24.5.2 ZEISS IN GLOBAL LIVE-CELL IMAGING MARKET
  • 24.5.3 PRODUCT OFFERINGS
  • 24.5.4 KEY STRATEGIES
  • 24.5.5 KEY STRENGTHS
  • 24.5.6 KEY OPPORTUNITIES
• 24.6 THERMO FISHER SCIENTIFIC
  • 24.6.1 BUSINESS OVERVIEW
  • 24.6.2 THERMO FISHER SCIENTIFIC IN GLOBAL LIVE-CELL IMAGING MARKET
  • 24.6.3 PRODUCT OFFERINGS
  • 24.6.4 KEY STRATEGIES
  • 24.6.5 KEY STRENGTHS
  • 24.6.6 KEY OPPORTUNITIES

25 OTHER PROMINENT VENDORS

• 25.1 AXION BIOSYSTEMS
  • 25.1.1 BUSINESS OVERVIEW
  • 25.1.2 PRODUCT OFFERINGS
• 25.2 BD
  • 25.2.1 BUSINESS OVERVIEW
  • 25.2.2 PRODUCT OFFERINGS
• 25.3 BIO-RAD LABORATORIES
  • 25.3.1 BUSINESS OVERVIEW
  • 25.3.2 PRODUCT OFFERINGS
• 25.4 BLUE-RAY BIOTECH
  • 25.4.1 BUSINESS OVERVIEW
  • 25.4.2 PRODUCT OFFERINGS
• 25.5 BRUKER
  • 25.5.1 BUSINESS OVERVIEW
  • 25.5.2 PRODUCT OFFERINGS
• 25.6 EPPENDORF
  • 25.6.1 BUSINESS OVERVIEW
  • 25.6.2 PRODUCT OFFERINGS
• 25.7 ETALUMA
  • 25.7.1 BUSINESS OVERVIEW
  • 25.7.2 PRODUCT OFFERINGS
• 25.8 GRACE BIO-LABS
  • 25.8.1 BUSINESS OVERVIEW
  • 25.8.2 PRODUCT OFFERINGS
• 25.9 IBIDI GMBH
  • 25.9.1 BUSINESS OVERVIEW
  • 25.9.2 PRODUCT OFFERINGS
• 25.10 INTELLIGENT IMAGING INNOVATIONS
  • 25.10.1 BUSINESS OVERVIEW
  • 25.10.2 PRODUCT OFFERINGS
• 25.11 KEYENCE CORPORATION
  • 25.11.1 BUSINESS OVERVIEW
  • 25.11.2 PRODUCT OFFERINGS
• 25.12 LOGOS BIOSYSTEMS
  • 25.12.1 BUSINESS OVERVIEW
  • 25.12.2 PRODUCT OFFERINGS
• 25.13 NANOENTEK
  • 25.13.1 BUSINESS OVERVIEW
  • 25.13.2 PRODUCT OFFERINGS
• 25.14 NANOLIVE SA
  • 25.14.1 BUSINESS OVERVIEW
  • 25.14.2 PRODUCT OFFERINGS
• 25.15 NIKON
  • 25.15.1 BUSINESS OVERVIEW
  • 25.15.2 PRODUCT OFFERINGS
• 25.16 EVIDENT
  • 25.16.1 BUSINESS OVERVIEW
  • 25.16.2 PRODUCT OFFERINGS
• 25.17 ONI
  • 25.17.1 BUSINESS OVERVIEW
  • 25.17.2 PRODUCT OFFERINGS
• 25.18 OXFORD INSTRUMENTS
  • 25.18.1 BUSINESS OVERVIEW
  • 25.18.2 PRODUCT OFFERINGS
• 25.19 PHASE FOCUS
  • 25.19.1 BUSINESS OVERVIEW
  • 25.19.2 PRODUCT OFFERINGS
• 25.20 PHASE HOLOGRAPHIC IMAGING PHI AB
  • 25.20.1 BUSINESS OVERVIEW
  • 25.20.2 PRODUCT OFFERINGS
• 25.21 PROTEINTECH GROUP
  • 25.21.1 BUSINESS OVERVIEW
  • 25.21.2 PRODUCT OFFERINGS
• 25.22 SARTORIUS AG
  • 25.22.1 BUSINESS OVERVIEW
  • 25.22.2 PRODUCT OFFERINGS
• 25.23 SONY BIOTECHNOLOGY
  • 25.23.1 BUSINESS OVERVIEW
  • 25.23.2 PRODUCT OFFERINGS
• 25.24 TOMOCUBE
  • 25.24.1 BUSINESS OVERVIEW
  • 25.24.2 PRODUCT OFFERINGS

26 REPORT SUMMARY

• 26.1 KEY TAKEAWAYS
• 26.2 STRATEGIC RECOMMENDATIONS

27 QUANTITATIVE SUMMARY

• 27.1 MARKET BY PRODUCT
  • 27.1.1 NORTH AMERICA: PRODUCT SEGMENTATION
  • 27.1.2 EUROPE: PRODUCT SEGMENTATION
  • 27.1.3 APAC: PRODUCT SEGMENTATION
  • 27.1.4 LATIN AMERICA: PRODUCT SEGMENTATION
  • 27.1.5 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION
• 27.2 MARKET BY TECHNIQUE
  • 27.2.1 NORTH AMERICA: TECHNIQUE SEGMENTATION
  • 27.2.2 EUROPE: TECHNIQUE SEGMENTATION
  • 27.2.3 APAC: TECHNIQUE SEGMENTATION
  • 27.2.4 LATIN AMERICA: TECHNIQUE SEGMENTATION
  • 27.2.5 MIDDLE EAST & AFRICA: TECHNIQUE SEGMENTATION
• 27.3 MARKET BY APPLICATION
  • 27.3.1 NORTH AMERICA: APPLICATION SEGMENTATION
  • 27.3.2 EUROPE: APPLICATION SEGMENTATION
  • 27.3.3 APAC: APPLICATION SEGMENTATION
  • 27.3.4 LATIN AMERICA: APPLICATION SEGMENTATION
  • 27.3.5 MIDDLE EAST & AFRICA: APPLICATION SEGMENTATION
• 27.4 MARKET BY END-USER
  • 27.4.1 NORTH AMERICA: END-USER SEGMENTATION
  • 27.4.2 EUROPE: END-USER SEGMENTATION
  • 27.4.3 APAC: END-USER SEGMENTATION
  • 27.4.4 LATIN AMERICA: END-USER SEGMENTATION
  • 27.4.5 MIDDLE EAST & AFRICA: END-USER SEGMENTATION
• 27.5 MARKET BY GEOGRAPHY
  • 27.5.1 EQUIPMENT: GEOGRAPHY SEGMENTATION
  • 27.5.2 CONSUMABLES: GEOGRAPHY SEGMENTATION
  • 27.5.3 SOFTWARE: GEOGRAPHY SEGMENTATION
  • 27.5.4 FLUORESCENCE MICROSCOPY: GEOGRAPHY SEGMENTATION
  • 27.5.5 CONFOCAL MICROSCOPY: GEOGRAPHY SEGMENTATION
  • 27.5.6 TRANSMITTED LIGHT MICROSCOPY: GEOGRAPHY SEGMENTATION
  • 27.5.7 OTHERS: GEOGRAPHY SEGMENTATION
  • 27.5.8 CELL BIOLOGY: GEOGRAPHY SEGMENTATION
  • 27.5.9 DRUG DISCOVERY: GEOGRAPHY SEGMENTATION
  • 27.5.10 DEVELOPMENTAL BIOLOGY: GEOGRAPHY SEGMENTATION
  • 27.5.11 STEM CELL RESEARCH: GEOGRAPHY SEGMENTATION
  • 27.5.12 PHARMA & BIOTECH COMPANIES: GEOGRAPHY SEGMENTATION
  • 27.5.13 ACADEMIC & RESEARCH INSTITUTES: GEOGRAPHY SEGMENTATION
  • 27.5.14 OTHERS: GEOGRAPHY SEGMENTATION

28 APPENDIX

• 28.1 ABBREVIATIONS

LIST OF EXHIBITS

• EXHIBIT 1 SEGMENTATION OF GLOBAL LIVE-CELL IMAGING MARKET
• EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
• EXHIBIT 3 LIVE-CELL IMAGING PROCESS
• EXHIBIT 4 IMPACT OF DEEP LEARNING & ARTIFICIAL INTELLIGENCE ENHANCE LIVE-CELL IMAGING TECHNIQUES
• EXHIBIT 5 IMPACT OF INCREASED INVESTMENTS IN CELL & GENE THERAPY PRODUCTS
• EXHIBIT 6 GLOBAL FUNDING FOR CELL & GENE THERAPY PRODUCTS 2017-2019 ($ BILLION)
• EXHIBIT 7 COMPANIES INVOLVED IN REGENERATIVE MEDICINE R&D ACTIVITIES 2017 & 2018
• EXHIBIT 8 IMPACT OF TRACKING SOLUTIONS FOR LIVE-CELL IMAGING
• EXHIBIT 9 IMPACT OF ADVANCES IN LIVE-CELL IMAGING
• EXHIBIT 10 IMPACT OF RISE IN NUMBER OF PATIENTS WITH CANCERS & INFECTIOUS DISEASES
• EXHIBIT 11 IMPACT OF ADOPTION OF HCS METHODS
• EXHIBIT 12 IMPACT OF NEW TECHNIQUES IN LIVE-CELL IMAGING
• EXHIBIT 13 IMPACT OF GROWTH IN R&D ACTIVITIES IN PHARMACEUTICAL INDUSTRY
• EXHIBIT 14 IMPACT OF HIGH COST OF LIVE-CELL IMAGING SYSTEMS
• EXHIBIT 15 IMPACT OF CELL VIABILITY & CELLULAR ENVIRONMENT MAINTENANCE CHALLENGES
• EXHIBIT 16 IMPACT OF PHOTOTOXICITY & PHOTOBLEACHING IN FLUORESCENCE MICROSCOPY
• EXHIBIT 17 GLOBAL LIVE-CELL IMAGING MARKET 2021-2027 ($ MILLION)
• EXHIBIT 18 GLOBAL LIVE-CELL IMAGING MARKET BY PRODUCT
• EXHIBIT 19 GLOBAL LIVE-CELL IMAGING MARKET BY TECHNIQUE
• EXHIBIT 20 GLOBAL LIVE-CELL IMAGING MARKET BY APPLICATION
• EXHIBIT 21 GLOBAL LIVE-CELL IMAGING MARKET BY END-USER
• EXHIBIT 22 GLOBAL LIVE-CELL IMAGING MARKET BY GEOGRAPHY
• EXHIBIT 23 FIVE FORCES ANALYSIS 2021
• EXHIBIT 24 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
• EXHIBIT 25 GLOBAL LIVE-CELL IMAGING MARKET BY PRODUCT
• EXHIBIT 26 GLOBAL LIVE-CELL IMAGING MARKET BY PRODUCT: INCREMENTAL GROWTH
• EXHIBIT 27 GLOBAL LIVE-CELL IMAGING MARKET BY PRODUCT: ABSOLUTE GROWTH
• EXHIBIT 28 GLOBAL LIVE-CELL IMAGING EQUIPMENT MARKET: INCREMENTAL & ABSOLUTE GROWTH COMPARISON
• EXHIBIT 29 GLOBAL LIVE-CELL IMAGING EQUIPMENT MARKET 2021-2027 ($ MILLION)
• EXHIBIT 30 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
• EXHIBIT 31 GLOBAL LIVE-CELL IMAGING CONSUMABLES MARKET: INCREMENTAL & ABSOLUTE GROWTH COMPARISON
• EXHIBIT 32 GLOBAL LIVE-CELL IMAGING CONSUMABLES MARKET 2021-2027 ($ MILLION)
• EXHIBIT 33 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
• EXHIBIT 34 GLOBAL LIVE-CELL IMAGING SOFTWARE MARKET: INCREMENTAL & ABSOLUTE GROWTH COMPARISON
• EXHIBIT 35 GLOBAL LIVE-CELL IMAGING SOFTWARE MARKET 2021-2027 ($ MILLION)
• EXHIBIT 36 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
• EXHIBIT 37 INCREMENTAL GROWTH BY TECHNIQUE 2021 & 2027
• EXHIBIT 38 GLOBAL LIVE-CELL IMAGING MARKET BY TECHNIQUE
• EXHIBIT 39 GLOBAL LIVE-CELL IMAGING MARKET BY TECHNIQUE: INCREMENTAL GROWTH
• EXHIBIT 40 GLOBAL LIVE-CELL IMAGING MARKET BY TECHNIQUE: ABSOLUTE GROWTH
• EXHIBIT 41 GLOBAL LIVE-CELL IMAGING MARKET BY FLUORESCENCE MICROSCOPY: INCREMENTAL & ABSOLUTE GROWTH
• EXHIBIT 42 GLOBAL LIVE-CELL IMAGING MARKET BY FLUORESCENCE MICROSCOPY 2021-2027 ($ MILLION)
• EXHIBIT 43 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
• EXHIBIT 44 GLOBAL LIVE-CELL IMAGING MARKET BY CONFOCAL MICROSCOPY: INCREMENTAL & ABSOLUTE GROWTH
• EXHIBIT 45 GLOBAL LIVE-CELL IMAGING BY CONFOCAL MICROSCOPY MARKET 2021-2027 ($ MILLION)
• EXHIBIT 46 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
• EXHIBIT 47 GLOBAL LIVE-CELL IMAGING MARKET BY TRANSMITTED LIGHT MICROSCOPY: INCREMENTAL & ABSOLUTE GROWTH
• EXHIBIT 48 GLOBAL LIVE-CELL IMAGING MARKET BY TRANSMITTED LIGHT MICROSCOPY 2021-2027 ($ MILLION)
• EXHIBIT 49 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
• EXHIBIT 50 GLOBAL LIVE-CELL IMAGING MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH
• EXHIBIT 51 GLOBAL LIVE-CELL IMAGING MARKET BY OTHERS 2021-2027 ($ MILLION)
• EXHIBIT 52 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
• EXHIBIT 53 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
• EXHIBIT 54 GLOBAL LIVE-CELL IMAGING MARKET BY APPLICATION
• EXHIBIT 55 GLOBAL LIVE-CELL IMAGING MARKET BY APPLICATION: INCREMENTAL GROWTH
• EXHIBIT 56 GLOBAL LIVE-CELL IMAGING MARKET BY APPLICATION: ABSOLUTE GROWTH
• EXHIBIT 57 GLOBAL LIVE-CELL IMAGING MARKET BY CELL BIOLOGY: INCREMENTAL & ABSOLUTE GROWTH
• EXHIBIT 58 GLOBAL LIVE-CELL IMAGING MARKET BY CELL BIOLOGY 2021-2027 ($ MILLION)
• EXHIBIT 59 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
• EXHIBIT 60 GLOBAL LIVE-CELL IMAGING MARKET BY DRUG DISCOVERY: INCREMENTAL & ABSOLUTE GROWTH
• EXHIBIT 61 GLOBAL LIVE-CELL IMAGING MARKET BY DRUG DISCOVERY 2021-2027 ($ MILLION)
• EXHIBIT 62 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
• EXHIBIT 63 GLOBAL LIVE-CELL IMAGING MARKET BY DEVELOPMENTAL BIOLOGY: INCREMENTAL & ABSOLUTE GROWTH
• EXHIBIT 64 GLOBAL LIVE-CELL IMAGING MARKET BY DEVELOPMENTAL BIOLOGY 2021-2027 ($ MILLION)
• EXHIBIT 65 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
• EXHIBIT 66 GLOBAL LIVE-CELL IMAGING MARKET BY STEM CELL RESEARCH: INCREMENTAL & ABSOLUTE GROWTH
• EXHIBIT 67 GLOBAL LIVE-CELL IMAGING MARKET BY STEM CELL RESEARCH 2021-2027 ($ MILLION)
• EXHIBIT 68 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
• EXHIBIT 69 INCREMENTAL GROWTH BY END-USER 2021 & 2027
• EXHIBIT 70 GLOBAL LIVE-CELL IMAGING MARKET BY END-USER
• EXHIBIT 71 GLOBAL LIVE-CELL IMAGING MARKET BY END-USER: INCREMENTAL GROWTH
• EXHIBIT 72 GLOBAL LIVE-CELL IMAGING MARKET BY END-USER: ABSOLUTE GROWTH
• EXHIBIT 73 GLOBAL LIVE-CELL IMAGING MARKET BY PHARMA & BIOTECH COMPANIES: INCREMENTAL & ABSOLUTE GROWTH
• EXHIBIT 74 GLOBAL LIVE-CELL IMAGING MARKET BY PHARMA & BIOTECH COMPANIES 2021-2027 ($ MILLION)
• EXHIBIT 75 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
• EXHIBIT 76 GLOBAL LIVE-CELL IMAGING MARKET BY ACADEMIC & RESEARCH INSTITUTES: INCREMENTAL & ABSOLUTE GROWTH
• EXHIBIT 77 GLOBAL LIVE-CELL IMAGING MARKET BY ACADEMIC & RESEARCH INSTITUTES 2021-2027 ($ MILLION)
• EXHIBIT 78 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
• EXHIBIT 79 GLOBAL LIVE-CELL IMAGING MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH
• EXHIBIT 80 GLOBAL LIVE-CELL IMAGING MARKET BY OTHERS 2021-2027 ($ MILLION)
• EXHIBIT 81 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
• EXHIBIT 82 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
• EXHIBIT 83 GLOBAL LIVE-CELL IMAGING MARKET BY GEOGRAPHY
• EXHIBIT 84 GLOBAL LIVE-CELL IMAGING MARKET BY GEOGRAPHY: KEY COUNTRIES (2021) ($ MILLION)
• EXHIBIT 85 GLOBAL LIVE-CELL IMAGING MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
• EXHIBIT 86 GLOBAL LIVE-CELL IMAGING MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
• EXHIBIT 87 NORTH AMERICA LIVE-CELL IMAGING MARKET: KEY COUNTRIES (2021)
• EXHIBIT 88 NORTH AMERICA LIVE-CELL IMAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
• EXHIBIT 89 NORTH AMERICA LIVE-CELL IMAGING MARKET 2021-2027 ($ MILLION)
• EXHIBIT 90 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
• EXHIBIT 91 INCREMENTAL GROWTH BY TECHNIQUE 2021 & 2027
• EXHIBIT 92 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
• EXHIBIT 93 INCREMENTAL GROWTH BY END-USER 2021 & 2027
• EXHIBIT 94 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
• EXHIBIT 95 US LIVE-CELL IMAGING MARKET 2021-2027 ($ MILLION)
• EXHIBIT 96 CANADA LIVE-CELL IMAGING MARKET 2021-2027 ($ MILLION)
• EXHIBIT 97 EUROPE LIVE-CELL IMAGING MARKET: KEY COUNTRIES (2021)
• EXHIBIT 98 EUROPE LIVE-CELL IMAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
• EXHIBIT 99 EUROPE LIVE-CELL IMAGING MARKET 2021-2027 ($ MILLION)
• EXHIBIT 100 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
• EXHIBIT 101 INCREMENTAL GROWTH BY TECHNIQUE 2021 & 2027
• EXHIBIT 102 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
• EXHIBIT 103 INCREMENTAL GROWTH BY END-USER 2021 & 2027
• EXHIBIT 104 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
• EXHIBIT 105 GERMANY LIVE-CELL IMAGING MARKET 2021-2027 ($ MILLION)
• EXHIBIT 106 FRANCE LIVE-CELL IMAGING MARKET 2021-2027 ($ MILLION)
• EXHIBIT 107 UK LIVE-CELL IMAGING MARKET 2021-2027 ($ MILLION)
• EXHIBIT 108 ITALY LIVE-CELL IMAGING MARKET 2021-2027 ($ MILLION)
• EXHIBIT 109 SPAIN LIVE-CELL IMAGING MARKET 2021-2027 ($ MILLION)
• EXHIBIT 110 APAC LIVE-CELL IMAGING MARKET: KEY COUNTRIES (2021)
• EXHIBIT 111 APAC LIVE-CELL IMAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
• EXHIBIT 112 APAC LIVE-CELL IMAGING MARKET 2021-2027 ($ MILLION)
• EXHIBIT 113 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
• EXHIBIT 114 INCREMENTAL GROWTH BY TECHNIQUE 2021 & 2027
• EXHIBIT 115 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
• EXHIBIT 116 INCREMENTAL GROWTH BY END-USER 2021 & 2027
• EXHIBIT 117 INCREMENTAL GROWTH IN APAC 2021 & 2027
• EXHIBIT 118 CHINA LIVE-CELL IMAGING MARKET 2021-2027 ($ MILLION)
• EXHIBIT 119 JAPAN LIVE-CELL IMAGING MARKET 2021-2027 ($ MILLION)
• EXHIBIT 120 INDIA LIVE-CELL IMAGING MARKET 2021-2027 ($ MILLION)
• EXHIBIT 121 SOUTH KOREA LIVE-CELL IMAGING MARKET 2021-2027 ($ MILLION)
• EXHIBIT 122 AUSTRALIA LIVE-CELL IMAGING MARKET 2021-2027 ($ MILLION)
• EXHIBIT 123 LATIN AMERICA LIVE-CELL IMAGING MARKET: KEY COUNTRIES (2021)
• EXHIBIT 124 LATIN AMERICA LIVE-CELL IMAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
• EXHIBIT 125 LATIN AMERICA LIVE-CELL IMAGING MARKET 2021-2027 ($ MILLION)
• EXHIBIT 126 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
• EXHIBIT 127 INCREMENTAL GROWTH BY TECHNIQUE 2021 & 2027
• EXHIBIT 128 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
• EXHIBIT 129 INCREMENTAL GROWTH BY END-USER 2021 & 2027
• EXHIBIT 130 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
• EXHIBIT 131 BRAZIL LIVE-CELL IMAGING MARKET 2021-2027 ($ MILLION)
• EXHIBIT 132 MEXICO LIVE-CELL IMAGING MARKET 2021-2027 ($ MILLION)
• EXHIBIT 133 ARGENTINA LIVE-CELL IMAGING MARKET 2021-2027 ($ MILLION)
• EXHIBIT 134 MIDDLE EAST & AFRICA LIVE-CELL IMAGING MARKET: KEY COUNTRIES (2021)
• EXHIBIT 135 MIDDLE EAST & AFRICA LIVE-CELL IMAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
• EXHIBIT 136 MIDDLE EAST & AFRICA LIVE-CELL IMAGING MARKET 2021-2027 ($ MILLION)
• EXHIBIT 137 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
• EXHIBIT 138 INCREMENTAL GROWTH BY TECHNIQUE 2021 & 2027
• EXHIBIT 139 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
• EXHIBIT 140 INCREMENTAL GROWTH BY END-USER 2021 & 2027
• EXHIBIT 141 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
• EXHIBIT 142 TURKEY LIVE-CELL IMAGING MARKET 2021-2027 ($ MILLION)
• EXHIBIT 143 SAUDI ARABIA LIVE-CELL IMAGING MARKET 2021-2027 ($ MILLION)
• EXHIBIT 144 SOUTH AFRICA LIVE-CELL IMAGING MARKET 2021-2027 ($ MILLION)
• EXHIBIT 145 UAE LIVE-CELL IMAGING MARKET 2021-2027 ($ MILLION)
• EXHIBIT 146 PURE AND DIVERSIFIED PLAYERS IN THE GLOBAL LIVE-CELL IMAGING MARKET
• EXHIBIT 147 GLOBAL LIVE-CELL IMAGING MARKET: KEY VENDORS STRENGTHS & CAPABILITY ANALYSIS
• EXHIBIT 148 MARKET POSITION OF MAJOR PLAYERS IN THE GLOBAL LIVE-CELL IMAGING MARKET

LIST OF TABLES

• TABLE 1 KEY CAVEATS
• TABLE 2 CURRENCY CONVERSION 2015-2021
• TABLE 3 COMMON BIOLOGICAL APPLICATIONS OF LIVE-CELL MICROSCOPY PROCEDURES
• TABLE 4 TYPICAL DURATION OF COMMONLY PERFORMED APPLICATIONS WITH LIVING CELLS
• TABLE 5 PARAMETERS TO MAINTAIN CELL HEALTH DURING LIVE IMAGING
• TABLE 6 VARIOUS COMPANIES THAT OFFER CONSUMABLES & ACCESSORIES FOR LIVE-CELL IMAGING
• TABLE 7 VARIOUS COMPANIES AND THEIR SOFTWARE FOR LIVE-CELL IMAGING
• TABLE 8 DANAHER: MAJOR PRODUCT OFFERINGS
• TABLE 9 AGILENT TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
• TABLE 10 PERKINELMER: MAJOR PRODUCT OFFERINGS
• TABLE 11 MERCK KGAA: MAJOR PRODUCT OFFERINGS
• TABLE 12 ZEISS: MAJOR PRODUCT OFFERINGS
• TABLE 13 THERMO FISHER SCIENTIFIC: MAJOR PRODUCT OFFERINGS
• TABLE 14 AXION BIOSYSTEMS: MAJOR PRODUCT OFFERINGS
• TABLE 15 BD: MAJOR PRODUCT OFFERINGS
• TABLE 16 BIO-RAD LABORATORIES: MAJOR PRODUCT OFFERINGS
• TABLE 17 BLUE-RAY BIOTECH: MAJOR PRODUCT OFFERINGS
• TABLE 18 BRUKER: MAJOR PRODUCT OFFERINGS
• TABLE 19 EPPENDORF: MAJOR PRODUCT OFFERINGS
• TABLE 20 ETALUMA: MAJOR PRODUCT OFFERINGS
• TABLE 21 GRACE BIO-LABS: MAJOR PRODUCT OFFERINGS
• TABLE 22 IBIDI GMBH: MAJOR PRODUCT OFFERINGS
• TABLE 23 INTELLIGENT IMAGING INNOVATIONS: MAJOR PRODUCT OFFERINGS
• TABLE 24 KEYENCE CORPORATION: MAJOR PRODUCT OFFERINGS
• TABLE 25 LOGOS BIOSYSTEMS: MAJOR PRODUCT OFFERINGS
• TABLE 26 NANOENTEK: MAJOR PRODUCT OFFERINGS
• TABLE 27 NANOLIVE SA: MAJOR PRODUCT OFFERINGS
• TABLE 28 NIKON: MAJOR PRODUCT OFFERINGS
• TABLE 29 EVIDENT: MAJOR PRODUCT OFFERINGS
• TABLE 30 ONI: MAJOR PRODUCT OFFERINGS
• TABLE 31 OXFORD INSTRUMENTS: MAJOR PRODUCT OFFERINGS
• TABLE 32 PHASE FOCUS: MAJOR PRODUCT OFFERINGS
• TABLE 33 PHASE HOLOGRAPHIC IMAGING PHI AB: MAJOR PRODUCT OFFERINGS
• TABLE 34 PROTEINTECH GROUP: MAJOR PRODUCT OFFERINGS
• TABLE 35 SARTORIUS AG: MAJOR PRODUCT OFFERINGS
• TABLE 36 SONY BIOTECHNOLOGY: MAJOR PRODUCT OFFERINGS
• TABLE 37 TOMOCUBE: MAJOR PRODUCT OFFERINGS
• TABLE 38 GLOBAL LIVE-CELL IMAGING MARKET BY PRODUCT 2021-2027 ($ MILLION)
• TABLE 39 GLOBAL LIVE-CELL IMAGING MARKET BY PRODUCT 2021-2027 (%)
• TABLE 40 NORTH AMERICA LIVE-CELL IMAGING MARKET BY PRODUCT 2021-2027 ($ MILLION)
• TABLE 41 NORTH AMERICA LIVE-CELL IMAGING MARKET BY PRODUCT 2021-2027 (%)
• TABLE 42 EUROPE LIVE-CELL IMAGING MARKET BY PRODUCT 2021-2027 ($ MILLION)
• TABLE 43 EUROPE LIVE-CELL IMAGING MARKET BY PRODUCT 2021-2027 (%)
• TABLE 44 APAC LIVE-CELL IMAGING MARKET BY PRODUCT 2021-2027 ($ MILLION)
• TABLE 45 APAC LIVE-CELL IMAGING MARKET BY PRODUCT 2021-2027 (%)
• TABLE 46 LATIN AMERICA LIVE-CELL IMAGING MARKET BY PRODUCT 2021-2027 ($ MILLION)
• TABLE 47 LATIN AMERICA LIVE-CELL IMAGING MARKET BY PRODUCT 2021-2027 (%)
• TABLE 48 MIDDLE EAST & AFRICA LIVE-CELL IMAGING MARKET BY PRODUCT 2021-2027 ($ MILLION)
• TABLE 49 MIDDLE EAST & AFRICA LIVE-CELL IMAGING MARKET BY PRODUCT 2021-2027 (%)
• TABLE 50 GLOBAL LIVE-CELL IMAGING MARKET BY TECHNIQUE 2021-2027 ($ MILLION)
• TABLE 51 GLOBAL LIVE-CELL IMAGING MARKET BY TECHNIQUE 2021-2027 (%)
• TABLE 52 NORTH AMERICA LIVE-CELL IMAGING MARKET BY TECHNIQUE 2021-2027 ($ MILLION)
• TABLE 53 NORTH AMERICA LIVE-CELL IMAGING MARKET BY TECHNIQUE 2021-2027 (%)
• TABLE 54 EUROPE LIVE-CELL IMAGING MARKET BY TECHNIQUE 2021-2027 ($ MILLION)
• TABLE 55 EUROPE LIVE-CELL IMAGING MARKET BY TECHNIQUE 2021-2027 (%)
• TABLE 56 APAC LIVE-CELL IMAGING MARKET BY TECHNIQUE 2021-2027 ($ MILLION)
• TABLE 57 APAC LIVE-CELL IMAGING MARKET BY TECHNIQUE 2021-2027 (%)
• TABLE 58 LATIN AMERICA LIVE-CELL IMAGING MARKET BY TECHNIQUE 2021-2027 ($ MILLION)
• TABLE 59 LATIN AMERICA LIVE-CELL IMAGING MARKET BY TECHNIQUE 2021-2027 (%)
• TABLE 60 MIDDLE EAST & AFRICA LIVE-CELL IMAGING MARKET BY TECHNIQUE 2021-2027 ($ MILLION)
• TABLE 61 MIDDLE EAST & AFRICA LIVE-CELL IMAGING MARKET BY TECHNIQUE 2021-2027 (%)
• TABLE 62 GLOBAL LIVE-CELL IMAGING MARKET BY APPLICATION 2021-2027 ($ MILLION)
• TABLE 63 GLOBAL LIVE-CELL IMAGING MARKET BY APPLICATION2021-2027 (%)
• TABLE 64 NORTH AMERICA LIVE-CELL IMAGING MARKET BY APPLICATION 2021-2027 ($ MILLION)
• TABLE 65 NORTH AMERICA LIVE-CELL IMAGING MARKET BY APPLICATION 2021-2027 (%)
• TABLE 66 EUROPE LIVE-CELL IMAGING MARKET BY APPLICATION 2021-2027 ($ MILLION)
• TABLE 67 EUROPE LIVE-CELL IMAGING MARKET BY APPLICATION 2021-2027 (%)
• TABLE 68 APAC LIVE-CELL IMAGING MARKET BY APPLICATION 2021-2027 ($ MILLION)
• TABLE 69 APAC LIVE-CELL IMAGING MARKET BY APPLICATION 2021-2027 (%)
• TABLE 70 LATIN AMERICA LIVE-CELL IMAGING MARKET BY APPLICATION 2021-2027 ($ MILLION)
• TABLE 71 LATIN AMERICA LIVE-CELL IMAGING MARKET BY APPLICATION 2021-2027 (%)
• TABLE 72 MIDDLE EAST & AFRICA LIVE-CELL IMAGING MARKET BY APPLICATION 2021-2027 ($ MILLION)
• TABLE 73 MIDDLE EAST & AFRICA LIVE-CELL IMAGING MARKET BY APPLICATION 2021-2027 (%)
• TABLE 74 GLOBAL LIVE-CELL IMAGING MARKET BY END-USER 2021-2027 ($ MILLION)
• TABLE 75 GLOBAL LIVE-CELL IMAGING MARKET BY END-USER 2021-2027 (%)
• TABLE 76 NORTH AMERICA LIVE-CELL IMAGING MARKET BY END-USER 2021-2027 ($ MILLION)
• TABLE 77 NORTH AMERICA LIVE-CELL IMAGING MARKET BY END-USER 2021-2027 (%)
• TABLE 78 EUROPE LIVE-CELL IMAGING MARKET BY END-USER 2021-2027 ($ MILLION)
• TABLE 79 EUROPE LIVE-CELL IMAGING MARKET BY END-USER 2021-2027 (%)
• TABLE 80 APAC LIVE-CELL IMAGING MARKET BY END-USER 2021-2027 ($ MILLION)
• TABLE 81 APAC LIVE-CELL IMAGING MARKET BY END-USER 2021-2027 (%)
• TABLE 82 LATIN AMERICA LIVE-CELL IMAGING MARKET BY END-USER 2021-2027 ($ MILLION)
• TABLE 83 LATIN AMERICA LIVE-CELL IMAGING MARKET BY END-USER 2021-2027 (%)
• TABLE 84 MIDDLE EAST & AFRICA LIVE-CELL IMAGING MARKET BY END-USER 2021-2027 ($ MILLION)
• TABLE 85 MIDDLE EAST & AFRICA LIVE-CELL IMAGING MARKET BY END-USER 2021-2027 (%)
• TABLE 86 GLOBAL LIVE-CELL IMAGING MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
• TABLE 87 GLOBAL LIVE-CELL IMAGING MARKET BY GEOGRAPHY 2021-2027 (%)
• TABLE 88 GLOBAL LIVE-CELL IMAGING EQUIPMENT MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
• TABLE 89 GLOBAL LIVE-CELL IMAGING EQUIPMENT MARKET BY GEOGRAPHY 2021-2027 (%)
• TABLE 90 GLOBAL LIVE-CELL IMAGING CONSUMABLES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
• TABLE 91 GLOBAL LIVE-CELL IMAGING CONSUMABLES MARKET BY GEOGRAPHY 2021-2027 (%)
• TABLE 92 GLOBAL LIVE-CELL IMAGING SOFTWARE MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
• TABLE 93 GLOBAL LIVE-CELL IMAGING SOFTWARE MARKET BY GEOGRAPHY 2021-2027 (%)
• TABLE 94 GLOBAL LIVE-CELL IMAGING MARKET BY FLUORESCENCE MICROSCOPY 2021-2027 ($ MILLION)
• TABLE 95 GLOBAL LIVE-CELL IMAGING MARKET BY FLUORESCENCE MICROSCOPY 2021-2027 (%)
• TABLE 96 GLOBAL LIVE-CELL IMAGING MARKET BY CONFOCAL MICROSCOPY 2021-2027 ($ MILLION)
• TABLE 97 GLOBAL LIVE-CELL IMAGING MARKET BY CONFOCAL MICROSCOPY 2021-2027 (%)
• TABLE 98 GLOBAL LIVE-CELL IMAGING MARKET BY TRANSMITTED LIGHT MICROSCOPY 2021-2027 ($ MILLION)
• TABLE 99 GLOBAL LIVE-CELL IMAGING MARKET BY TRANSMITTED LIGHT MICROSCOPY 2021-2027 (%)
• TABLE 100 GLOBAL LIVE-CELL IMAGING MARKET BY OTHERS 2021-2027 ($ MILLION)
• TABLE 101 GLOBAL LIVE-CELL IMAGING MARKET BY OTHERS 2021-2027 (%)
• TABLE 102 GLOBAL LIVE-CELL IMAGING MARKET BY CELL BIOLOGY 2021-2027 ($ MILLION)
• TABLE 103 GLOBAL LIVE-CELL IMAGING MARKET BY CELL BIOLOGY 2021-2027 (%)
• TABLE 104 GLOBAL LIVE-CELL IMAGING MARKET BY DRUG DISCOVERY 2021-2027 ($ MILLION)
• TABLE 105 GLOBAL LIVE-CELL IMAGING MARKET BY DRUG DISCOVERY 2021-2027 (%)
• TABLE 106 GLOBAL LIVE-CELL IMAGING MARKET BY DEVELOPMENTAL BIOLOGY 2021-2027 ($ MILLION)
• TABLE 107 GLOBAL LIVE-CELL IMAGING MARKET BY DEVELOPMENTAL BIOLOGY 2021-2027 (%)
• TABLE 108 GLOBAL LIVE-CELL IMAGING MARKET BY STEM CELL RESEARCH 2021-2027 ($ MILLION)
• TABLE 109 GLOBAL LIVE-CELL IMAGING MARKET BY STEM CELL RESEARCH 2021-2027 (%)
• TABLE 110 GLOBAL LIVE-CELL IMAGING MARKET BY PHARMA & BIOTECH COMPANIES 2021-2027 ($ MILLION)
• TABLE 111 GLOBAL LIVE-CELL IMAGING MARKET BY PHARMA & BIOTECH COMPANIES 2021-2027 (%)
• TABLE 112 GLOBAL LIVE-CELL IMAGING MARKET BY ACADEMIC & RESEARCH INSTITUTES 2021-2027 ($ MILLION)
• TABLE 113 GLOBAL LIVE-CELL IMAGING MARKET BY ACADEMIC & RESEARCH INSTITUTES 2021-2027 (%)
• TABLE 114 GLOBAL LIVE-CELL IMAGING MARKET BY OTHERS 2021-2027 ($ MILLION)
• TABLE 115 GLOBAL LIVE-CELL IMAGING MARKET BY OTHERS 2021-2027 (%)